12 Jul 2019 --- Chemical manufacturer Kaneka Europe Holding Company (Kaneka) is looking to pay out €38 million to buy the 60 percent of probiotic company AB-Biotics that it does not already own. Kaneka is offering €5 per share, which represents a premium of 19 percent on the average price over the last six months and nearly the same price as at the end of the last session when it was €4.98 per share. This means that AB-Biotics is now valued at €63 million – a steep increase from March 2018 when it was listed at €22 million, just before Kaneka was announced as a shareholder.
